FRESH-PEF195-en
Observational usage and effectiveness of candesartan in heart failure treatment in France
SISTOLA
| Name | Country code |
|---|---|
| France | fr |
['Clinical data','Biological data','Participant-reported health data']
Individuals
| Topic | Vocabulary |
|---|---|
| Cardiology and vascular medicine | health theme |
| Congestive heart failure | cim-11 |
| Healthcare system determinants: Use of care | health determinant |
| Healthcare system determinants | health determinant |
{"level_sex_clusion_I":[{"value":"Male","concept":{"vocab":"MeSH","vocabURI":"D008297"}},{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}},{"value":"Aged, 80 and over (80 years and more)","concept":{"vocab":"MeSH","vocabURI":"D000369"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patients starting or who have recently started (less than 30 days) a treatment with candesartan for heart failure","clusion_E":""}
| Name |
|---|
| Florence;THOMAS-DELECOURT |
| Name | Role |
|---|---|
| ASTRAZENECA (FRANCE) | sponsor |
| TAKEDA FRANCE SAS | sponsor |
| Name |
|---|
| ASTRAZENECA (FRANCE) |
| Agency name |
|---|
| CNIL |
['Through organizations (health services or institutions, schools, businesses, etc.)']
['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']
Access on specific project only
Observational Study
| Start | End |
|---|---|
| 2008-01-01 | 2010-01-01 |
{"value":"To be defined","extLink":[]}
| Name | |
|---|---|
| Florence;THOMAS-DELECOURT | florence.thomas@astrazeneca.com |